Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients - Archive ouverte HAL Access content directly
Journal Articles Journal of Autoimmunity Year : 2022

Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients

Frédéric Pène
  • Function : Author
Laurent Argaud
  • Function : Author
Julien Mayaux
  • Function : Author
Remi Coudroy
  • Function : Author
Elie Azoulay
  • Function : Author
Yacine Tandjaoui-Lambiotte
  • Function : Author
Auguste Dargent
  • Function : Author
François Beloncle
  • Function : Author
Jean-Herlé Raphalen
  • Function : Author
Antoine Troger
  • Function : Author
Nicolas de Prost
  • Function : Author
Jérôme Devaquet
  • Function : Author
Damien Contou
  • Function : Author
Samuel Gaugain
  • Function : Author
Pierre Trouiller
  • Function : Author
Steven Grangé
  • Function : Author
Stanislas Ledochowski
  • Function : Author
Jérémie Lemarie
  • Function : Author
Stanislas Faguer
  • Function : Author
Vincent Degos
  • Function : Author
Fichier principal
Vignette du fichier
2022 Azoulay et al., Prevalence.pdf (32.41 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03783864 , version 1 (22-09-2022)

Identifiers

Cite

Lévi-Dan Azoulay, Marc Pineton de Chambrun, Romaric Larcher, Frédéric Pène, Laurent Argaud, et al.. Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients. Journal of Autoimmunity, 2022, 133, pp.102908. ⟨10.1016/j.jaut.2022.102908⟩. ⟨hal-03783864⟩
19 View
82 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More